Browsing: Biochemical recurrence

The EMBARK trial recently showed that adding enzalutamide to ADT for high risk biochemically recurrent prostate cancer significantly improved 5-year…

Top Line: Biochemically recurrent (BCR) prostate cancer is a unique entity as it often happens with no evidence of gross…

Top Line: Is biochemical recurrence a good surrogate endpoint for overall survival in the treatment of prostate cancer?The Study: Biochemical…